How does Delaware law address drug compounding in pharmacies?

Delaware law emphasizes that drug compounding in pharmacies must adhere to the standards established by the United States Pharmacopeia (USP) guidelines along with relevant state regulations. This ensures that any compounded medications are prepared with a consistent level of quality and safety. USP guidelines provide detailed protocols for the compounding process, including necessary equipment, sterile techniques, and quality control measures to ensure that compounded drugs are safe and effective for patient use. By requiring compliance with both USP guidelines and state regulations, Delaware aims to protect public health while allowing pharmacies to meet specific patient needs that cannot be fulfilled by commercial products.

The focus on these rigorous standards helps ensure that any compounded medications are properly formulated, minimizing the risk of contamination, dosing errors, or ineffective treatment that could arise from substandard compounding practices. This legal framework is crucial for maintaining the integrity of pharmaceutical services within the state.